HomeFBRX • NASDAQ
Forte Biosciences Inc
add
$7.85
0.26%
Pre-market:(14.78%)-1.16
$6.69
Closed: May 19, 7:09:09 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.12M | 106.61% |
Net income | -15.66M | -111.00% |
Net profit margin | — | — |
Earnings per share | -1.37 | 65.75% |
EBITDA | -16.11M | -106.68% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.86M | 50.62% |
Total assets | 47.46M | 48.23% |
Total liabilities | 9.03M | 171.07% |
Total equity | 38.43M | — |
Shares outstanding | 6.58M | — |
Price to book | 1.34 | — |
Return on assets | -73.95% | — |
Return on capital | -88.68% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.66M | -111.00% |
Cash from operations | -10.36M | -55.32% |
Cash from investing | 36.29M | 604,916.67% |
Cash from financing | -2.32M | -28,925.00% |
Net change in cash | 23.61M | 453.42% |
Free cash flow | -8.50M | -99.45% |
Previous close
$7.83
Day range
$7.75 - $8.75
Year range
$4.11 - $28.68
Market cap
51.68M USD
Avg Volume
25.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2007
Headquarters
Website
Employees
14
